(1.27±0.11 vs. 1.06±0.11 mM extracellular calcium, P < 0.01) and a slightly higher extracellular calcium was necessary to raise the cytosolic calcium concentration to a given level in neonatal than in adult bovine parathyroid cells. In individual neonatal and adult cell preparations, there was a close correlation between the set-point for secretion and the "set-point" for cytosolic calcium (r = 0.832, P < 0.001). In cells from five human parathyroid adenomas, which had an increase in setpoint for secretion, the extracellular calcium concentration necessary to raise the cytosolic calcium concentration to a given level was slightly greater than in the neonatal cells. In four preparations of human parathyroid cells there was a significant correlation between the set-points for secretion and cytosolic calcium (r = 0.856, P < 0.01). Because neonatal bovine and pathological human parathyroid glands show cellular hyperplasia, we studied the temporal relationship between cellular proliferation and the regulation of PTH release and cytosolic calcium concentration in cultured bovine parathyroid cells. increased significantly in culture from 104±10.1 counts/well on day 1 (first 24 h in culture) to 588±188 and 6,156±649 counts/well on days 2 and 4, respectively. In cultured cells on day 1, high Ca" (2-3 mM) inhibited maximal PTH release by 58.8±3.2%, which decreased significantly (P <0.001) to 38.2±1.9 and 17.1±3.7% on days 2 and 4, respectively. The cytosolic calcium observed at 3 mM calcium on day 1 was 701±43 nM, which declined to 466±60 and 314±14 nM on days 2 and 4 (P < 0.05). There was a close correlation between this progressive decrease in maximal inhibition of PTI4 release and the cytosolic calcium at high extracellular calcium in cultured cells (r = 0.99, P < 0.001). Thus, during active proliferation of cultured cells, there is an alteration in the regulation of cytosolic calcium and PTH release by extracellular calcium. These results suggest that decreased sensitivity to the inhibitory effects of extracellular calcium on PTH release may result from a low cytosolic calcium at a given extracellular calcium concentration, and changes in the regulation of PTH release and cytosolic calcium by extracellular calcium may be related to enhanced cellular proliferation.
Introduction
The normal parathyroid cell shows an inverse, sigmoidal relationship between parathyroid hormone (PTH)' secretion and the extracellular ionized calcium concentration (1-3). In a variety of settings, there may be changes in the sensitivity or "set-point" (the calcium concentration half-maximally suppressing PTH release) of the parathyroid gland for calcium. For example, parathyroid tissue from hypercalcemic, neonatal calves shows an increase in set-point for calcium bdth in vivo (4) and in vitro (2) . In primary hyperparathyroidism, pathological parathyroid tissue shows an increase in set-point that may contribute to the hypercalcemia in this disorder (3) . Parathyroid cells maintained in culture for 3-4 d also develop reduced sensitivity to the suppressive effects of calcium on parathyroid hormone release (5) .
The elevated set-point for calcium in primary hyperparathyroidism may be reduced toward normal with the divalent cation ionophore A23187 (6) . Moreover, increased extracellular potassium concentrations, which may decrease cytosolic calcium through an alteration in Na'-Ca+ exchange, promote an increase in set-point in bovine parathyroid cells (7) . Thus, indirect evidence suggests that changes in set-point may be related to alterations in the regulation of the cytosolic calcium concentration. The recent development of the calcium-sensitive intracellular dye QUIN-2 has made it feasible to determine directly the cytosolic calcium concentration in dispersed parathyroid cells (8) . In the present studies, we have used QUIN-2 to examine whether alterations in parathyroid cellular sensitivity to calcium might be related to changes in the relationship between the extracellular and cytosolic calcium concentrations. The results suggest that decreased sensitivity to the suppressive effects of extracellular calcium on PTH release may result from an inappropriately low cytosolic calcium concentration at a given extracellular calcium concentration, and that changes in the regulation of PTH secretion and cytosolic calcium by extracellular calcium may be related to enhanced cellular proliferation.
Methods
Dispersed bovine and human parathyroid cells were prepared by digestion with collagenase and DNase as described previously (3, 9) . Parathyroid cells prepared in this fashion maintain high ratios of cellular potassium to cellular sodium (7) and have high levels of ATP (Brown, E. M., unpublished data). Moreover, PTH release is linear for several hours and is inhibited by up to 80% by calcium concentrations similar to those which inhibit PTH secretion in vivo (3) . Dispersed parathyroid cells contained no visible fat cells by sudan staining or in cytocentrifuge preparations, and showed >95% exclusion of trypan blue.
Dispersed bovine parathyroid cells were cultured for 4 d as recently described (5): cells were prepared under sterile conditions and plated onto fibronectin-coated cluster wells (2 or 4 cm2; Costar, Cambridge, MA) in DMEM-F12 medium with 5 ug/ml insulin, 15% newborn calf serum, and antibiotics (5) . Plating efficiency is =34% under these conditions and the cells approach a confluent monolayer after 3-4 d. Cultured cells were removed from the plates with 0.25% trypsin (Gibco Laboratories, Grand Island, NY) in Hank's balanced salt solution with 1.0 mM CaCl2 and 0.5 mM MgSO4.
For loading with QUIN-2, parathyroid cells (20 X 106/ml) were incubated with the acetoxymethyl ester of QUIN-2 (10-20 MM) (Lan- caster Synthesis, Ltd., Lancaster, England) at 37°C for 20 min in Eagle's minimal essential medium (Earle's salts with bicarbonate, Ca++ and Mge' deleted) supplemented with 0.02 M Hepes (adjusted to pH 7.47 with NaOH), 0.2% bovine serum albumin (BSA), 1.0 mM CaCI2, and 0.5 mM MgSO4 ("standard medium") (8). The cellular suspension was then diluted 10-fold with standard medium and incubated for an additional 20-60 min. The cellular pellet was washed three times with a saline solution that contained 0.025 M Hepes (adjusted to pH 7.47 with NaOH), 125 mM NaCl, 5 mM KCl, I mM CaC12, 0.5 mM MgSO4, 1 gm/L dextrose, I mM Na2HPO4, and 0.1% BSA ("saline"). The washed cellular pellet was resuspended in 3 ml of the saline solution with 0.1% BSA for determination of cellular fluorescence at a cellular concentration of 7-10 X 106 cells/ml. Fluorescence was monitored in thermostatted cuvettes (37°C) in a Perkin-Elmer MPF3 spectrofluorimeter (excitation 339 nm, emission 492 nM). Cellular suspensions were mechanically stirred during all experiments, except when recording was interrupted for 10-20 s during the addition of CaC12. Extracellular calcium was raised by the addition of 0.15 M CaC12; direct determination of calcium concentrations in these solutions by atomic absorption spectrometry showed that they were within 3% of the calculated value. Fluorescence was monitored for 3-10 min after the addition of CaC12, or until the signal was stable as specified below. The calibration of cellular fluorescence (F) at the end of a study was achieved by cellular lysis with the detergent Triton X-100 Radioimmunoassay for PTH in samples from incubations with bovine parathyroid cells was performed in duplicate on triplicate incubation vials as previously described (9) , using an anti-bovine PTH antiserum raised in a sheep, GW-l, which recognizes intact hormone and C-terminal fragments of PTH. In studies with human parathyroid cells, PTH 4 experiments. and exposed to progressively higher calcium concentrations, there was a stepwise increase in cellular fluorescence (not shown). When cytosolic free calcium concentrations were calculated as described in Methods, there was a corresponding rise in cytosolic calcium concentrations with increasing levels of extracellular calcium (Fig. 1 B) . Cytosolic calcium increased more at lower levels of extracellular calcium in cells from adult than in those from neonatal parathyroid tissue, although this difference was not statistically significant by t testing.
The relationship between the effect of extracellular calcium on cytosolic calcium and PTH release in neonatal and adult parathyroid tissue. The results shown in Fig. 1 suggested that changes in the sensitivity of the secretory process to extracellular calcium might be related to alterations in the relationship between the extracellular and cytosolic calcium concentrations. To investigate this possibility further, the set-point for secretion was plotted against the cytosolic calcium concentration at the set-point in a series of cell preparations from neonatal and adult bovine parathyroid tissue (Fig. 2 A) . The cytosolic calcium concentration associated with half-maximal inhibition of secretion was independent of the set-point for PTH release, which suggests that inhibition of hormonal secretion occurred at similar cytosolic calcium concentrations regardless of the extracellular calcium concentration necessary to modify these parameters. For each cell preparation, the set-point for secretion was then plotted against the "set-point" for cytosolic calcium or the extracellular calcium concentration necessary to achieve the average cytosolic calcium concentration associated with the secretory set-point for all the cell preparations (i.e., 308 nM, see Fig. 2 A) (Fig. 2 B) . There was a close correlation (r = 0.832, P < 0.001) between these parameters for cell preparations from neonatal and adult bovine parathyroid tissue with set-points ranging from 0.93 to 1.48 mM.
Effect of varying extracellular calcium concentrations on cytosolic calcium concentration and PTH release in pathological human parathyroid tissue. Fig. 3 shows the relationship between the extracellular and cytosolic calcium concentrations in dispersed parathyroid cells from 12 adenomas and five glands from four patients with uremic secondary hyperparathyroidism. In cells from these pathological human parathyroid glands, the extracellular calcium concentration necessary to raise the cytosolic calcium concentration to a given level was comparable to or greater than that for neonatal bovine parathyroid cells.
For studies on the effects of extracellular calcium on PTH release in human parathyroid tissue, an N-terminal antiserum was employed to minimize the interpretational difficulties inherent with the use of antisera recognizing inactive, C-terminal fragments of the hormone. The characteristics of this assay are described in Methods. Preliminary studies with bovine parathyroid cells showed that the set-point for secretion was identical when measured with the N-and C-terminal assays (1.2+0.045 and 1.2±0.054 mM, respectively, n = 3), although maximal suppressibility was slightly greater with the N-assay (70±4.5 vs. 54±1.5%).
PTH release as a function of the extracellular calcium concentration was measured in dispersed parathyroid cells from five adenomas and three glands from patients with uremic secondary hyperparathyroidism. Set-points using the N-terminal assay for the adenomas and tissue showing secondary hyperplasia were comparable to those we have found previously using a C-terminal assay (1.33+0.15 vs. 1.26+0. 13 Regulation ofParathyroid Hormone Release and Cytosolic Calcium (Fig. 4) . In one cell preparation, however, despite extracellular calcium-induced increases in cytosolic calcium comparable to those with adult bovine parathyroid tissue, there was markedly impaired suppression of PTH release (Fig. 5) . In four cell preparations in which there was >50% suppression of PTH secretion by 2-3 mM calcium, the cytosolic calcium concentration at which PTH release was half-maximally suppressed averaged 304 nM, nearly identical to that for bovine parathyroid cells (308 nM; see above). In addition, as with adult and neonatal bovine tissue, there was a significant correlation between the set-point for secretion and the extracellular calcium concentration necessary to raise the cytosolic calcium concentration to the average value at which PTH release was half-maximally suppressed (r = 0.856, P < 0.01) (Fig. 6) .
Effect of extracellular calcium on PTH secretion and cytosolic calcium concentration in cultured bovine parathyroid cells as a function of the culture interval. We recently found that bovine parathyroid cells proliferating in culture over 3-4 d lose normal suppressibility of PTH release by extracellular calcium similar to the most severe abnormalities in parathyroid adenomas (5) . Because this parathyroid cell culture system might provide a model for investigating the changes in parathyroid function in hyperparathyroidism, we examined the relationship between the regulation of PTH release and cytosolic , A Figure 4 . The relationship EXTRACELLULAR[C47", mM Figure 5 . The relationship between the effect of extracellular calcium on cytosolic calcium and PTH release in one parathyroid adenoma. PTH release and cytosolic calcium were determined as described above. PTH release was inhibited by 29% of maximal and the cytosolic calcium concentration increased to 565 nM at 2 mM extracellular calcium. The (Fig. 7 A) . The set-point in cultured cells on day 1 was 1.35 mM calcium, slightly higher than the value of 1.30 mM calcium observed with acutely dispersed cells. As cultured parathyroid cells proliferated in culture, however, the percentage of maximal inhibition of PTH release decreased to *38.2±1.86% (n = 14) on day 2 and then to *17.1±3.73% on day 4 SET-POI/r FOR CY7CSO /CC in *1,n mlE'CI Figure 6 . The relationship between the set-point for secretion and the set-point for cytosolic calcium (the extracellular calcium concentration necessary to raise the cytosolic calcium concentration to the average value at which PTH release was half-maximally suppressed) in four parathyroid adenomas. There was a close correlation (r = 0.856, P < 0.01) between these two parameters (solid line). The dashed line indicates the relationship between these parameters for bovine parathyroid cells. Fig. 7 B for comparison. On day 1, before the development of the reduced sensitivity of PTH secretion to extracellular calcium in cultured parathyroid cells, basal cytosolic calcium concentration decreased from 179±7.6 nM in dispersed to 106±8.5 nM in cultured cells (P < 0.001), and there was a shift in the relationship between extracellular and cytosolic calcium concentrations to the right, which indicated that a higher extracellular calcium concentration was necessary to raise the cytosolic calcium concentration to a level comparable to that in the dispersed cells (Fig. 7 B) . At 3 mM extracellular calcium, however, the cultured cells on day 1 achieved a cytosolic calcium concentration of 701±43.1 nM (n = 4), which was not significantly different from the value of 646±68 nM observed in dispersed cells at 2 mM extracellular calcium (P > 0.05). With the decline in calcium sensitivity of PTH release to extracellular calcium in cultured cells on day 2 and subsequently on day 4, the cytosolic calcium concentration achieved at high extracellular calcium (3 mM) was *466±59.7 nM on day 2 and **314±13.5 nM on day 4 of the culture interval (*P < 0.05 and **P < 0.001, compared with day 1). Using linear regression analysis, the progressive decrease in the percentage of maximal inhibition of PTH release in cultured cells correlated with the reduced rise in cytosolic calcium concentration at 3 mM extracellular calcium from day 1 to day 4 (r = 0.99, P < 0.001).
To exclude the possibility that the reduced rise in cytosolic free calcium concentration was cells, n = 17-21). We have previously shown that viable cell number increased significantly from 289,000±63,000 cells/ well on day I to 530,000±60,000 cells/well on day 4 (n = 6; P <0.02). This increment in cell number, when plotted semilogarithmically against time, revealed a doubling time of -4 d. Total cellular protein also increased significantly from 40.00±1.40 Ag/well on day 1 to 177.60±57.10 jig/well on day 4 (n = 9; P < 0.035) (5). Thus, this 59-fold increase in 3H-thymidine incorporation from day 1 until day 4 corresponded to an approximately twofold increment in cell number and fourfold increase in cellular protein (5) . Autoradiographic studies on near confluent monolayers of cultured parathyroid cells (day 4) revealed uptake of [3H]thymidine predominantly in the parathyroid cells, with only 6.73±1.26% of the labeled nuclei representing spindle-shaped cells, which were presumably fibroblasts (n = 4). There was a significant correlation between the temporal changes in 3H-thymidine incorporation and both maximal suppression of PTH release (r = -0.997, P < 0.01) as well as cytosolic calcium concentration (r = -0.995, P < 0.01) at high extracellular calcium (2-3 mM).
Discussion
The mechanisms by which extracellular calcium regulates PTH release have not been established with certainty. We recently showed a close correlation between the effects of extracellular calcium on PTH release and cytosolic calcium in dispersed bovine parathyroid cells (8) . Since the effects of elevated extracellular calcium concentrations on PTH release can be mimicked by addition of the divalent cation ionophore ionomycin at a fixed calcium concentration (15) (Fig. 1 B) . Moreover, our results indicated that changes in PTH release were closely linked to changes in the cytosolic calcium concentration, in that there was a significant correlation between the set-point for secretion in neonatal and adult bovine parathyroid cells and the extracellular calcium concentration necessary to achieve the mean cytosolic calcium concentration (308 nM), at which half-maximal inhibition of PTH release occurred (Fig. 2 B) (r = 0.832, P < 0.001). Keaton et al. (4) have suggested that the increase in parathyroid glandular set-point for calcium and associated hypercalcemia in the neonatal calf may be a model for human hyperparathyroidism. In fact, there is a decreased sensitivity to the suppressive effects of extracellular calcium on PTH release in both primary and secondary hyperparathyroidism (16) (17) (18) . It was of interest, therefore, to compare the effects of extracellular calcium on cytosolic calcium and PTH release in pathological human parathyroid cells.
Because bPTH(1-84) and supernatants from human parathyroid cells do not dilute in parallel in our C-terminal PTH assay, we used an N-terminal assay to compare the effects of extracellular calcium on PTH release and cytosolic calcium in pathological human parathyroid tissue. In addition, the use of an N-terminal assay largely obviates the difficulties inherent in interpreting secretory data in which there may be release of inactive C-terminal fragments of PTH. While characterizing this assay, we observed that the set-points for secretion in primary and secondary hyperparathyroidism using the N-terminal assay were similar to those we reported previously using a C-terminal assay (1.33±0.15 vs. 1.26±0.13 and 1.22±0.03 vs. 1.17±0.19 mM, respectively) (14) . In addition, the set-points for secretion in neonatal bovine parathyroid cells were identical in the N-and C-terminal assays (1.2±0.045 and 1.2±0.054, respectively). These results suggest that the two assays yield comparable estimates of parathyroid cellular sensitivity to calcium.
In parathyroid adenomas, a slightly greater extracellular calcium was necessary to raise the cytosolic calcium to a given level than in neonatal bovine cells, which is consistent with the slightly higher secretory set-point in the former. In four of five adenomas studied here, changes in PTH release and cytosolic calcium occurred over a similar range of extracellular calcium concentrations. Moreover, the cytosolic calcium concentration at which there was half-maximal inhibition of PTH secretion was nearly identical to the value found in dispersed bovine parathyroid cells (304 vs. 308 nM, respectively). As with the adult and neonatal bovine parathyroid cells, there was a significant correlation in a small number of cases between the set-point for secretion and the set-point for cytosolic calcium, or the extracellular calcium concentration necessary to raise cytosolic calcium concentration to the average value at which PTH was half-maximally suppressed (r = 0.856, P < 0.01). This suggests that the sensitivity of PTH secretion to calcium in bovine as well as pathological human parathyroid tissue is related to the cytosolic calcium concentration.
In one parathyroid adenoma, however, there was only 29% suppression of maximal PTH release at 2 mM calcium despite an increase in the cytosolic calcium to levels comparable with that in adult bovine parathyroid cells. The poor suppressibility of this cell preparation in the presence of an elevated cytosolic calcium suggests a defect distal to the mechanisms which regulate the cytosolic calcium concentration. We have previously shown that there is considerable heterogeneity in the suppressibility of PTH release from pathological human parathyroid tissue by calcium (3, 16) . Unlike hyperparathyroid tissue, which displayed a .50% suppression of PTH release and a reduction in the set-point for calcium in the presence of the calcium ionophore A23187, parathyroid adenomas that were resistant to the effects of extracellular calcium on hormone secretion also showed no effects of the calcium ionophore on PTH secretion (6) (5) . DNA synthesis was initiated within the first 24 h of the culture period, as 3H-thymidine incorporation DNA on day 1 was significantly greater than the 35.7±5.24 counts observed in acutely dispersed cells. Preceding the development of the reduced sensitivity of hormonal secretion to extracellular calcium, there was a significant decrement in the basal cytosolic calcium concentration on day 1 which coincided with the onset of active cellular proliferation. It is possible, then, that this low cytosolic calcium concentration promoted the enhanced cellular proliferation observed in these cells and that, as postulated by Parfitt (22) and others, the parathyroid cell divides to maintain an increased hormonal output at a lower calcium concentration. The changes in cellular proliferation as a function of the culture interval correlated significantly with the gradual reduction in the effects of high extracellular calcium on PTH release (r = 0.997, P < 0.01) and cytosolic calcium (r = 0.995, P < 0.01). Although it is possible that the increment in 3H-thymidine incorporation into DNA observed in the cultured cells was due to the enhanced cellular proliferation of other cell types, such as fibroblasts, autoradiographic studies revealed uptake of 3H-thymidine predominantly in parathyroid cells. Moreover, while the change in 3H-thymidine incorporation into DNA could have been a consequence of an increase in the intracellular pool of thymidine, or a decrease in thymidylate synthetase (12) , three parameters of cellular proliferation provided evidence that cellular proliferation was enhanced in vitro. Thus, in cultured bovine parathyroid cells, with the onset and during the active period of cellular proliferation, there is an alteration in the regulation of cytosolic calcium and PTH release by extracellular calcium, which indicates that there is an association between changes in cellular proliferation and secretory function.
Because of the similarities between cultured bovine parathyroid cells and neonatal bovine and pathological human parathyroid cells, it is possible that the abnormal secretory function in the latter two cell types may be causally related to enhanced proliferative activity as well. Although we did not determine 3H-thymidine incorporation or other indices of cellular proliferation in pathological cells, it is of interest that Lloyd et al. (23) measured 3H-thytidine incorporation in parathyroid adenomas and found that DNA synthesis correlated with the preoperative serum PTH and calcium concentration, but not with tumor weight. These studies suggest that more severe secretory abnormalities are produced by parathyroid adenomas undergoing more active cellular proliferation.
Differentiated cellular function may be controlled by the state of cellular proliferation. As demonstrated in other tissues, rapidly proliferating cells may lose the ability to express certain physiologic characteristics (24, 25 
